From product safety to high multiple stocks to breakthrough health discoveries, the dynamic life sciences industry faces a wide range of challenges and opportunities. A global team of industry specialists can help map out risk strategies and approaches as new issues emerge.
Worldwide clientele includes 34 of the top 50 pharmaceutical firms…seven of the top 10 generics firms…35 of the top 50 medical device companies…19 of the top 50 biotech companies
Employers must stay current on evolving legal developments regarding marijuana use while maintaining safe and drug-free workplaces.
Drug development and marketing. Pricing challenges amid health care reform. Breakthrough health discoveries and “fast track” approvals. The continuing growth of generics and emerging biosimilars. A complex and evolving global regulatory environment. Amid this dynamic and ever-changing business climate, Marsh’s life sciences industry experts develop and implement strategies tailored to your unique needs.
Among our areas of specialty:
By helping reduce your total cost of risk with tailored solutions — insurance brokerage, advisory, and risk management services — Marsh can help you minimize the volatility and severity of risk, protect assets, and maintain profitability.
For clients across the global pharmaceutical industry — biopharma, specialty drugs, generics, animal health, and nutraceuticals — Marsh offers solutions that include:
For clients across the global biotech industry — from large global enterprises to small specialty and “incubator” firms — Marsh offers solutions that include:
For medical device manufacturers, diagnostics companies, and consumer health aid product marketers, Marsh offers solutions that include:
For life sciences service providers — wholesale distributors, research institutes, contract manufacturers (CMOs), and contract developers (CDMOs) — Marsh offers solutions that encompass: